Olivier Espitia - Concepedia

Author

Olivier Espitia

Also Known As

A. Élias, B Crichi, C. Blanchard-Delaunay, Carole HERVE, Espitia, Olivier, F Couturaud, F. Couturaud, French Study Group for Large Vessel Vasculitis (GEFA), J. Catella, Maxime Samson

234

Publications

2.1K

Citations

H-Index

Concepts

All Affiliations

Inserm Nantes Université Centre Hospitalier Universitaire de Nantes Assistance Publique – Hôpitaux de Paris Université de Caen Normandie

About

Olivier Espitia is an author at Inserm specializing in medicine, public health, and thrombosis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	15	612
2	Public Health	9	9	274
3	Biostatistics	1	1	42
4	Cell Biology	1	1	42
5	Cellular Physiology	1	1	42

Olivier Espitia

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
Management of giant cell arteritis: Recommendations of the French Study Group for Large Vessel Vasculitis (GEFA) Boris Bienvenu, K.H. Ly, M. Lambert, La Revue de Médecine Interne RheumatologyGlomerulonephritisVasculitisLarge Vessel VasculitisVascular Surgery	2016	190
Identification of genomic differences among peripheral arterial beds in atherosclerotic and healthy arteries Marja Steenman, Olivier Espitia, Blandine Maurel, Scientific Reports	2018	155
Giant Cell Arteritis with or without Aortitis at Diagnosis. A Retrospective Study of 22 Patients with Longterm Followup Olivier Espitia, A. Néel, Christophe Leux, The Journal of Rheumatology	2012	92
Efficacy and safety of biologics in relapsing polychondritis: a French national multicentre study Guillaume Moulis, G. Pugnet, N. Costedoat‐Chalumeau, Annals of the Rheumatic Diseases	2018	67
Long‐Term Outcome and Prognostic Factors of Complications in Thromboangiitis Obliterans (Buerger's Disease): A Multicenter Study of 224 Patients Alexandre Le Joncour, Simon Soudet, Axelle Dupont, Journal of the American Heart Association Prognostic FactorsLogistic AnalysisThrombosisVenous ThrombosisHematology	2018	65
Tocilizumab in Giant Cell Arteritis: A Multicenter Retrospective Study of 34 Patients Alexis Régent, S. Redeker, Alban Deroux, The Journal of Rheumatology	2016	62
Different patterns and specific outcomes of large-vessel involvements in giant cell arteritis Hubert de Boysson, É. Liozon, Olivier Espitia, Journal of Autoimmunity Vascular DiseaseVasculitisDifferent PatternsSpecific OutcomesPathology	2019	52
Efficacy and safety of TNF-α antagonists and tocilizumab in Takayasu arteritis: multicentre retrospective study of 209 patients A. Mékinian, Lucie Biard, Lorenzo Dagna, Lara D. Veeken	2021	48
Anti–programmed death ligand 1 immunotherapies in cancer patients with pre-existing systemic sclerosis: A postmarketed phase IV safety assessment study Marion Panhaleux, Olivier Espitia, Benjamin Terrier, European Journal of Cancer Cancer ImmunosurveillanceOncologyAutoimmune DiseaseSystemic TreatmentImmune Regulation	2021	46
Implication of molecular vascular smooth muscle cell heterogeneity among arterial beds in arterial calcification Olivier Espitia, Mathias Chatelais, Marja Steenman, PLoS ONE Vascular DiseaseArterial CalcificationFemoral ArteriesPathologyCellular Physiology	2018	42

Page 1